SEMA4D
Basic information
Region (hg38): 9:89360786-89498130
Previous symbols: [ "SEMAJ", "C9orf164" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SEMA4D gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | |||||
missense | 53 | 67 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 55 | 15 | 19 |
Variants in SEMA4D
This is a list of pathogenic ClinVar variants found in the SEMA4D region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-89363482-C-T | SEMA4D-related disorder | Benign (Oct 18, 2019) | ||
9-89363849-G-A | Likely benign (Jun 21, 2018) | |||
9-89363868-G-A | SEMA4D-related disorder | Benign (Oct 18, 2019) | ||
9-89376938-C-A | SEMA4D-related disorder | Benign (Oct 28, 2019) | ||
9-89376952-G-A | SEMA4D-related disorder | Likely benign (Jan 31, 2023) | ||
9-89378700-G-A | SEMA4D-related disorder | Benign (Nov 26, 2019) | ||
9-89378760-G-C | not specified | Uncertain significance (Aug 21, 2023) | ||
9-89378781-C-T | not specified | Uncertain significance (Apr 28, 2022) | ||
9-89378809-C-T | SEMA4D-related disorder | Benign (Feb 23, 2019) | ||
9-89378841-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
9-89378893-G-A | SEMA4D-related disorder | Likely benign (Jun 27, 2019) | ||
9-89378898-A-G | not specified | Uncertain significance (Apr 26, 2023) | ||
9-89378915-A-G | not specified | Uncertain significance (Oct 06, 2022) | ||
9-89378917-C-T | SEMA4D-related disorder | Likely benign (Apr 01, 2024) | ||
9-89378918-G-A | not specified | Uncertain significance (Jun 27, 2022) | ||
9-89378931-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
9-89378939-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
9-89378940-G-A | not specified | Likely benign (May 10, 2022) | ||
9-89379088-G-A | SEMA4D-related disorder | Likely benign (Mar 14, 2019) | ||
9-89379092-C-T | not specified | Uncertain significance (Apr 27, 2022) | ||
9-89379111-G-A | SEMA4D-related disorder | Benign (Jan 29, 2020) | ||
9-89379146-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
9-89379186-G-A | SEMA4D-related disorder | Benign (Feb 22, 2019) | ||
9-89379234-C-A | not specified | Uncertain significance (Jan 23, 2024) | ||
9-89379234-C-T | not specified | Uncertain significance (Jun 11, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SEMA4D | protein_coding | protein_coding | ENST00000450295 | 14 | 137344 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.975 | 0.0253 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.997 | 460 | 524 | 0.877 | 0.0000324 | 5644 |
Missense in Polyphen | 88 | 158.38 | 0.55561 | 1720 | ||
Synonymous | 0.451 | 222 | 231 | 0.962 | 0.0000165 | 1710 |
Loss of Function | 4.79 | 6 | 37.8 | 0.159 | 0.00000186 | 447 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000121 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000489 | 0.000272 |
Finnish | 0.0000469 | 0.0000462 |
European (Non-Finnish) | 0.0000180 | 0.0000176 |
Middle Eastern | 0.000489 | 0.000272 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cell surface receptor for PLXN1B and PLXNB2 that plays an important role in cell-cell signaling. Promotes reorganization of the actin cytoskeleton and plays a role in axonal growth cone guidance in the developing central nervous system. Regulates dendrite and axon branching and morphogenesis. Promotes the migration of cerebellar granule cells and of endothelial cells. Plays a role in the immune system; induces B-cells to aggregate and improves their viability (in vitro). Promotes signaling via SRC and PTK2B/PYK2, which then mediates activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Interaction with PLXNB1 mediates activation of RHOA. {ECO:0000269|PubMed:16055703, ECO:0000269|PubMed:19788569, ECO:0000269|PubMed:20877282, ECO:0000269|PubMed:8876214}.;
- Pathway
- Axon guidance - Homo sapiens (human);Developmental Biology;Sema4D mediated inhibition of cell attachment and migration;Sema4D induced cell migration and growth-cone collapse;Sema4D in semaphorin signaling;Other semaphorin interactions;Semaphorin interactions;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.224
Intolerance Scores
- loftool
- 0.787
- rvis_EVS
- 0.12
- rvis_percentile_EVS
- 62.24
Haploinsufficiency Scores
- pHI
- 0.235
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.477
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.725
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sema4d
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- sema4d
- Affected structure
- trunk
- Phenotype tag
- abnormal
- Phenotype quality
- curved
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;neural crest cell migration;positive regulation of protein phosphorylation;immune response;cell adhesion;negative regulation of cell adhesion;regulation of cell shape;negative regulation of alkaline phosphatase activity;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of cell migration;regulation of cell projection organization;negative regulation of apoptotic process;positive regulation of GTPase activity;ossification involved in bone maturation;negative regulation of osteoblast differentiation;positive regulation of collateral sprouting;regulation of dendrite morphogenesis;negative regulation of axon extension involved in axon guidance;positive regulation of peptidyl-tyrosine phosphorylation;negative regulation of peptidyl-tyrosine phosphorylation;negative chemotaxis;leukocyte aggregation;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis
- Cellular component
- extracellular space;plasma membrane;integral component of plasma membrane
- Molecular function
- transmembrane signaling receptor activity;signaling receptor binding;protein binding;semaphorin receptor binding;signaling receptor activity;neuropilin binding;chemorepellent activity